This review looked at the effect on blood cholesterol of soy protein containing isoflavones. Total cholesterol, lowdensity lipoprotein cholesterol and triacylglycerol levels were all reduced, while high-density lipoprotein cholesterol levels were increased. There are some problems with the review that could affect the reliability of its findings.
Results of the review
Twenty-three RCTs (1,381 participants)were included. Since some studies had more than two arms, 34 comparisons were included.
Soy protein containing isoflavones decreased total cholesterol; the mean difference was -0.22 mmol/L (95% confidence interval, CI: -0.29, -0.16). LDL was also lowered (mean difference -0.21 mmol/L, 95% CI: -0.30, -0.13), as were triacylglycerol levels (mean difference -0.109 mmol/L, 95% CI: -0.16, -0.05).
HDL levels were increased with soy proteins; the mean difference was 0.04 mmol/L (95% CI: 0.00, 0.07).
Subgroup analysis.
Total cholesterol was reduced more in men than in women: mean changes of -0.26 and -0.16 mmol/L, respectively. Those with hypercholesterolaemia had greater reductions than those with normal cholesterol levels: changes of -0.25 and -0.17 mmol/L, respectively. In the regression analysis, the amount of soy protein containing isoflavones was independently associated with the change in total cholesterol. When the results were analysed according to quartiles, based on initial lipid levels, there was no significant differences in the responses to treatment.
The authors stated that funnel plots for the outcome total cholesterol indicated no significant publication bias.
Full details of other results were presented.
Authors' conclusions
Soy protein containing isoflavones significantly reduced total cholesterol, LDL cholesterol and triacylglycerol, and significantly increased HDL cholesterol. The changes were related to level and duration of intake, and the gender and initial serum lipid levels of the participants.
CRD commentary
The aims of this review were clearly stated. The database search was limited to PubMed and only articles published in English were included. It is therefore possible that other relevant studies were missed, and this could affect the results of the review. The methods of the review (study selection, data extraction) were not described; bias can be introduced at these stages of a review. There was no mention of any quality assessment. There is some confusion in the tables and text about the numbers of included participants. Although the authors considered heterogeneity, in some analyses they pooled studies where the forest plots indicated that studies should not have been pooled because heterogeneity was too great. Some studies included more than two treatment arms and the authors used the same control groups more than once within the pooled analysis; this might have distorted the results. In addition, when a large number of subgroup analyses are performed it is always possible that some chance effects are identified. The authors' conclusions should be interpreted in the light of these comments.
